Helicobacter pylori: A debated factor in gastroesophageal reflux disease

Digestive Diseases

Volumn 19, Issue 2, 2001, Pages 127-133

  Sharma, Prateek ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Epidemiology; Gastroesophageal reflux disease; Helicobacer pylori; PPI therapy

Indexed keywords

PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR;

ATROPHIC GASTRITIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ERADICATION THERAPY; ESOPHAGUS DISEASE; EUROPE; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; LOWER ESOPHAGUS SPHINCTER; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STOMACH PH; UNITED STATES;

ADENOCARCINOMA; ANTI-ULCER AGENTS; BARRETT ESOPHAGUS; GASTRIC ACID; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PROGNOSIS; PROTON PUMPS; RISK FACTORS; STOMACH NEOPLASMS;

EID: 0034853374     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050667     Document Type: Review

References (37)

1. Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: A model
2. Hypothesis: The changing relationships of Helicobacter pylori and humans. Implications for health and disease
3. Opposing time trends of peptic ulcer and reflux disease
4. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease
5. The effect of ammonia on omeprazole-induced reduction of gastric acidity in subjects with Helicobacter pylori infection
6. Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma
7. The prevalence of Helicobacter pylori gastritis in patients with reflux oesophagitis: A case-control study
8. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis
9. Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: A study from the East
10. Helicobacter pylori and gastro-oesophageal reflux disease - Clinical implications and management
11. Curing Helicobacter pylori infection in patients with duodenal ulcer disease may provoke reflux esophagitis
12. Association of Helicobacter pylori genotype with gastroesophageal reflux disease and other upper gastrointestinal diseases
13. High incidence of reflux oesophagitis after eradication therapy for Helicobacter pylori: Impacts of hiatal hernia and corpus gastritis
14. Recurrent symptoms and gastro-oesophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori infection
15. Symptomatic benefit 1-3 years after H. pylori eradication in ulcer disease: Impact of gastroesophageal reflux disease
16. Helicobacter pylori infection and chronic gastric acid hyposecretion
17. Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis
18. Corpus gastritis is protective against reflux oesophagitis
19. Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux
20. The effect of Helicobacter pylori eradication on gastro-oesophageal reflux
21. The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy
22. Helicobacter pylori infection potentiates the inhibition of gastric acid secretion by omeprazole
23. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer
24. Helicobacter pylori in gastro-oesophageal reflux disease: Causal agent, independent or protective factor?
25. Helicobacter pylori infection, reflux esophagaitis and atrophic gastritis: An unexplored triangle
26. Secretagogue-specific effects of interleukin-1 on gastric acid secretion
27. Mucosal tumor necrosis factor-alpha, interleukin-1β, and interleukin-8 production in patients with Helicobacter pylori infection
28. The effect of Helicobacter pylori eradication on intragastric pH during dosing with lansoprazole or ranitidine
29. Gastric Helicobacter pylori infection accelerates healing of reflux esophagitis during treatment with the proton pump inhibitor pantoprazole
30. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease
31. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication
32. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report
33. Lack of effect of acid suppression therapy on gastric atrophy
34. Recent advances in Barrett's esophagus: Short-segment Barrett's esophagus and cardia intestinal metaplasia
35. The sero-prevalence of cagA positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease
36. + strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma
37. Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia and Barrett's adenocarcinoma